521 related articles for article (PubMed ID: 18080227)
21. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological and immunohistochemical features of extragastrointestinal stromal tumors: report of two cases.
Nakagawa M; Akasaka Y; Kanai T; Takabayashi T; Miyazawa N
Surg Today; 2005; 35(4):336-40. PubMed ID: 15815855
[TBL] [Abstract][Full Text] [Related]
23. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
24. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
25. [CD117 contribution in the diagnosic of mesenchymal tumors of the digestive tract].
Khadija B; Saadia B; Ines C; Sami K; Mohamed J; Zina C; Nidhammeddine K; Mohamed MZ; Slim H
Tunis Med; 2005 Nov; 83(11):669-71. PubMed ID: 16422363
[TBL] [Abstract][Full Text] [Related]
26. Gastrointestinal stromal tumors: review on morphology, diagnosis and management.
Fülöp E; Marcu S; Milutin D; Borda A
Rom J Morphol Embryol; 2009; 50(3):319-26. PubMed ID: 19690756
[TBL] [Abstract][Full Text] [Related]
27. [Difficulties in diagnosing and treating GIST: report and analysis of a case].
Testi W; Staffieri C; Consiglio FM; Genovese A; Cirianni D; Ranalli M; Bing C; Tumbiolo S
Chir Ital; 2005; 57(4):515-20. PubMed ID: 16060193
[TBL] [Abstract][Full Text] [Related]
28. Gastrointestinal stromal tumors: clinical pathological review of a personal series.
Mattioli F; Puglisi M; Ceppa P; Peresi M; Borgonovo G; Ansaldo G; Varaldo E; Milone L; Assalino M; Torre GC
Chir Ital; 2005; 57(5):579-87. PubMed ID: 16241088
[TBL] [Abstract][Full Text] [Related]
29. Surgical management and clinical outcome of gastrointestinal stromal tumor of the colon and rectum.
Chen CW; Wu CC; Hsiao CW; Fang FC; Lee TY; Che FC; Tsai WC; Jao SW
Z Gastroenterol; 2008 Aug; 46(8):760-5. PubMed ID: 18759198
[TBL] [Abstract][Full Text] [Related]
30. Pediatric gastrointestinal stromal tumors and leiomyosarcoma.
Cypriano MS; Jenkins JJ; Pappo AS; Rao BN; Daw NC
Cancer; 2004 Jul; 101(1):39-50. PubMed ID: 15221987
[TBL] [Abstract][Full Text] [Related]
31. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
Zheng S; Chen LR; Wang HJ; Chen SZ
Hepatogastroenterology; 2007 Dec; 54(80):2285-90. PubMed ID: 18265649
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal stromal tumors.
Popescu I; Andrei S
Chirurgia (Bucur); 2008; 103(2):155-70. PubMed ID: 18457093
[TBL] [Abstract][Full Text] [Related]
33. Surgical resection of esophageal gastrointestinal stromal tumors.
Lee HJ; Park SI; Kim DK; Kim YH
Ann Thorac Surg; 2009 May; 87(5):1569-71. PubMed ID: 19379907
[TBL] [Abstract][Full Text] [Related]
34. High incidence of microscopic gastrointestinal stromal tumors in the stomach.
Kawanowa K; Sakuma Y; Sakurai S; Hishima T; Iwasaki Y; Saito K; Hosoya Y; Nakajima T; Funata N
Hum Pathol; 2006 Dec; 37(12):1527-35. PubMed ID: 16996566
[TBL] [Abstract][Full Text] [Related]
35. Gastrointestinal stromal tumors (GISTs): analysis of 20 cases.
Bölükbasi H; Nazli O; Tansug T; Bozdag AD; Isgiider AS; Yaman I; Haciyanli M; Genc H
Hepatogastroenterology; 2006; 53(69):385-8. PubMed ID: 16795978
[TBL] [Abstract][Full Text] [Related]
36. [Differential diagnosis and treatment of esophageal stromal tumors and smooth muscle tumors].
Zhang X; Rong TH; Wu QL; Fu JH; Long H; Zhang LJ; Ma GW; Su XD; Li XD; Wang DF; Hu Y; Yang H
Ai Zheng; 2006 Jul; 25(7):901-5. PubMed ID: 16831287
[TBL] [Abstract][Full Text] [Related]
37. Microscopic gastrointestinal stromal tumors in esophageal and intestinal surgical resection specimens: a clinicopathologic, immunohistochemical, and molecular study of 19 lesions.
Agaimy A; Wünsch PH; Dirnhofer S; Bihl MP; Terracciano LM; Tornillo L
Am J Surg Pathol; 2008 Jun; 32(6):867-73. PubMed ID: 18408593
[TBL] [Abstract][Full Text] [Related]
38. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of gastrointestinal stromal tumors.
Bertin M; Angriman I; Scarpa M; Mencarelli R; Ranzato R; Ruffolo C; Polese L; Iacobone M; D'Amico DF
Hepatogastroenterology; 2007; 54(73):124-8. PubMed ID: 17419245
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal stromal tumors: clinical and pathological analysis of 24 cases.
Zepeda-Gomez S; Nuncio JF; Maldonado H; Arista-Nasr J; Sánchez E; Schmulson M; Uscanga L
Rev Invest Clin; 2004; 56(4):443-8. PubMed ID: 15587289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
